Michael Cruse - 25 Aug 2021 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (OKUR)

Role
Senior VP-Corporate Operations
Signature
/s/ Vineet R. Jindal, Attorney-in-Fact
Issuer symbol
OKUR
Transactions as of
25 Aug 2021
Net transactions value
+$18,616
Form type
4
Filing time
26 Aug 2021, 17:51:54 UTC
Next filing
14 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPHM Common Stock Purchase $18,616 +2,500 $7.45 2,500 25 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction was $7.4464. The shares were purchased at a range of prices between $7.425 and $7.45. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.